Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

NCT02589847 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Infection

Interventions

BIOLOGICAL: RBX2660
DRUG: Standard of Care Antibiotics

Sponsor

Rebiotix Inc.